Skip to main content

Table 2 Between-group comparison of VTE incidence

From: Comparing the vascular thromboembolic events following arteriovenous fistula in Chinese population with end-stage renal diseases receiving Clopidogrel versus Beraprost sodium therapy: a retrospective cohort study

Variable

CL (n = 112)

BPS (n = 110)

P - value

Total incidence of VTEs

27/112

13/110

0.02*a

VTE incidence

 During the first Mos

16/112

6/110

0.03*a

 During the second Mos

3/112

2/110

0.64a

 from the third Mos to data cut-off

8/112

5/110

0.41a

  1. CL clopidogrel, BPS beraprost sodium, VTEs vascular thromboembolic events, Mos month
  2. *Statistically significant values
  3. aAnalysed using the Chi-square test